NO942335L - Substituerte imidazolderivater, deres fremstilling og anvendelse - Google Patents

Substituerte imidazolderivater, deres fremstilling og anvendelse

Info

Publication number
NO942335L
NO942335L NO942335A NO942335A NO942335L NO 942335 L NO942335 L NO 942335L NO 942335 A NO942335 A NO 942335A NO 942335 A NO942335 A NO 942335A NO 942335 L NO942335 L NO 942335L
Authority
NO
Norway
Prior art keywords
compounds
pct
preparation
inden
dihydro
Prior art date
Application number
NO942335A
Other languages
English (en)
Other versions
NO942335D0 (no
NO304227B1 (no
Inventor
Arto Johannes Karjalainen
Raimo Einari Virtanen
Arja Leena Karjalainen
Marie Marjatta Eloranta
Jarmo Sakari Salonen
Hannu Tapani Sipila
Antti Sakari Haapalinna
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of NO942335D0 publication Critical patent/NO942335D0/no
Publication of NO942335L publication Critical patent/NO942335L/no
Publication of NO304227B1 publication Critical patent/NO304227B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Resins (AREA)
NO942335A 1991-12-20 1994-06-17 Substituerte imidazolderivater, preparat som inneholder disse og deres anvendelse NO304227B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919127050A GB9127050D0 (en) 1991-12-20 1991-12-20 Substituted imidazole derivatives and their preparation and use
PCT/FI1992/000349 WO1993013074A1 (en) 1991-12-20 1992-12-18 Substituted imidazole derivatives and their preparation and use

Publications (3)

Publication Number Publication Date
NO942335D0 NO942335D0 (no) 1994-06-17
NO942335L true NO942335L (no) 1994-06-20
NO304227B1 NO304227B1 (no) 1998-11-16

Family

ID=10706581

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942335A NO304227B1 (no) 1991-12-20 1994-06-17 Substituerte imidazolderivater, preparat som inneholder disse og deres anvendelse

Country Status (17)

Country Link
US (1) US5498623A (no)
EP (1) EP0618906B1 (no)
JP (1) JP3276371B2 (no)
AT (1) ATE165350T1 (no)
AU (1) AU664584B2 (no)
CA (1) CA2117305C (no)
DE (1) DE69225240T2 (no)
DK (1) DK0618906T3 (no)
ES (1) ES2115046T3 (no)
FI (1) FI104968B (no)
GB (1) GB9127050D0 (no)
HK (1) HK1008962A1 (no)
HU (1) HU220043B (no)
NO (1) NO304227B1 (no)
PL (1) PL172532B1 (no)
RU (1) RU2120440C1 (no)
WO (1) WO1993013074A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312669D0 (en) * 1993-06-18 1993-08-04 Orion Yhtymae Oy New opticla isomers
FR2735776B1 (fr) * 1995-06-22 1997-07-18 Synthelabo Derives de 2,3-dihydro-1h-indole, leur preparation et leur application en therapeutique
GB9520150D0 (en) 1995-10-03 1995-12-06 Orion Yhtymae Oy New imidazole derivatives
US20020143007A1 (en) * 1996-02-02 2002-10-03 Garvey David S. Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
US6469065B1 (en) 1996-02-02 2002-10-22 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use
US6388090B2 (en) 2000-01-14 2002-05-14 Orion Corporation Imidazole derivatives
FI20000073A0 (fi) * 2000-01-14 2000-01-14 Orion Yhtymae Oy Uusia imidatsolijohdannaisia
US8188126B2 (en) 2002-05-16 2012-05-29 Pierre Fabre Medicament Imidazolic compounds and use thereof as alpha-2 adrenergic receptors
GB0226076D0 (en) 2002-11-08 2002-12-18 Rp Scherer Technologies Inc Improved formulations containing substituted imidazole derivatives
FI20022007A0 (fi) * 2002-11-08 2002-11-08 Juvantia Pharma Ltd Oy Oromukosaalinen valmiste ja menetelmä sen valmistamiseksi
CN106316812A (zh) 2009-07-24 2017-01-11 Dpx精细化学奥地利两合公司 作为中间体的二氢化茚衍生物
JP2013500983A (ja) * 2009-07-31 2013-01-10 ドクター・レディーズ・ラボラトリーズ・リミテッド フィパメゾールの調製
EP2502917A1 (en) 2011-03-17 2012-09-26 Santhera Pharmaceuticals (Schweiz) AG Solid state crystalline forms of 4-(2-ethyl-5-fluoro-2,3-dihydro-1H-inden-2-yl)-1H-imidazole
ES2861502T3 (es) * 2015-11-05 2021-10-06 Univ Louisville Res Found Inc Anestesia y analgesia locales y regionales
WO2024160908A1 (en) * 2023-02-01 2024-08-08 Univerza V Ljubljani N,n-dialkyl-4-(2-ethylindan-2-yl)-1h-imidazole-1-carboxamides and related compounds for treatment of neurodegenerative diseases

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1282535A (en) * 1970-03-02 1972-07-19 Pfizer (2-IMIDAZOLIN-2-YLAMINO)SUBSTITUTED BENZO[b]THIOPHENES
US3927023A (en) * 1974-05-24 1975-12-16 Warner Lambert Co Imidazolyl benzofurans
US3927018A (en) * 1974-12-23 1975-12-16 Sandoz Ag 3-(2-Methyl-1-imidazolyl)-3-phenyl-1-(3H)isobenzofuranones
IL66242A0 (en) * 1981-07-23 1982-11-30 Erba Farmitalia N-imidazolyl derivatives of 1,2,3,4-tetrahydro-naphthalene,indan and 2-substituted-1-chroman,their preparation and pharmaceutical compositions containing them
NZ201219A (en) * 1981-07-28 1984-10-19 Reckitt & Colmann Prod Ltd Dihydrobenzofuranyl-2-imidazolines and pharmaceutical compositions
ES523609A0 (es) * 1982-07-05 1985-03-01 Erba Farmitalia Procedimiento para preparar derivados n-imidazolilicos de compuestos biciclicos.
GB8409884D0 (en) * 1984-04-17 1984-05-31 Detexomat Machinery Ltd Transporting fabric pieces
GB2167408B (en) * 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use
FI81092C (fi) * 1986-05-15 1990-09-10 Farmos Oy Foerfarande foer framstaellning av terapeutiskt aktiva 4(5)-(2,3-dihydro-1h-inden-2-yl)-imidazolderivat.
JP2855341B2 (ja) * 1988-06-10 1999-02-10 武田薬品工業株式会社 新規2―置換クマラン誘導体
IL91542A0 (en) * 1988-10-06 1990-04-29 Erba Carlo Spa N-imidazolyl-and n-imidazolyl-methyl derivatives of substituted bicyclic compounds,their preparation and pharmaceutical compositions containing them
GB2225782A (en) * 1988-12-09 1990-06-13 Farmos Group Limited Imidazole derivatives useful for treatment of diabetes
GB9020128D0 (en) * 1990-09-14 1990-10-24 Reckitt & Colmann Prod Ltd Imidazoline derivatives
JP3050916B2 (ja) * 1991-12-23 2000-06-12 モービル・オイル・コーポレーション 酸素透過性の低いフィルム
GB9127430D0 (en) * 1991-12-27 1992-02-19 Scras Benzofuranylimidazole derivatives

Also Published As

Publication number Publication date
HK1008962A1 (en) 1999-05-21
EP0618906A1 (en) 1994-10-12
JP3276371B2 (ja) 2002-04-22
EP0618906B1 (en) 1998-04-22
PL172532B1 (en) 1997-10-31
US5498623A (en) 1996-03-12
NO942335D0 (no) 1994-06-17
FI942882A (fi) 1994-06-16
FI942882A0 (fi) 1994-06-16
ATE165350T1 (de) 1998-05-15
JPH07506087A (ja) 1995-07-06
RU2120440C1 (ru) 1998-10-20
HU9401823D0 (en) 1994-09-28
DK0618906T3 (da) 1999-01-25
AU3160593A (en) 1993-07-28
AU664584B2 (en) 1995-11-23
NO304227B1 (no) 1998-11-16
DE69225240T2 (de) 1998-08-27
WO1993013074A1 (en) 1993-07-08
GB9127050D0 (en) 1992-02-19
ES2115046T3 (es) 1998-06-16
HU220043B (hu) 2001-10-28
HUT67548A (en) 1995-04-28
FI104968B (fi) 2000-05-15
RU94031215A (ru) 1996-04-20
DE69225240D1 (de) 1998-05-28
CA2117305A1 (en) 1993-07-08
CA2117305C (en) 2003-11-25

Similar Documents

Publication Publication Date Title
DK0618906T3 (da) Substituerede imidazolderivater og deres fremstilling og anvendelse
DK0894084T3 (da) Kanelsyrederivater og deres anvendelse som integrinantagonister
DK0613458T3 (da) Acykliske ethylendiaminderivater som substans P receptorantagonister
PT641328E (pt) Derivados aza-biciclicos em ponte como antagonistas da substancia p
DK0889877T3 (da) Meta-substituerede phenylenderivater og deres anvendelse som alfav-beta3-integrin-antagonister eller -inhibitorer
DE69709624D1 (de) Chinazolinverbindungen
DK0597088T3 (da) Nye imidazolderivater, deres fremstilling og terapeutiske anvendelser
ES2149777T3 (es) Derivados de triazol que tienen actividad antifungica.
NO963706L (no) Benzenkondenserte heterosykliske derivater og deres anvendelse
NZ228722A (en) Substituted indole and indazole derivatives and pharmaceutical compositions
DE69413831D1 (de) Phenoxyphenylcyclopentenyl-hydroxyharnstoffe
ATE203022T1 (de) 4-(6-fluor-1,2-benzisoxazolyl)-1-piperidinyl- propoxy-chromen-4-on-derivate,ihre herstellung und ihre verwendung in der behandlung von psychosen, schizophrenie und angstzuständen
FI955707A (fi) Indolijohdannaiset steroidi-5alfa-reduktaasin inhibiittoreina
NO20002154L (no) Nye heterocykliske substituerte alfa-hydroksykarboksylsyre- derivater
ATE338749T1 (de) Derivate von 3-phenyl-n-(2-(4-benzyl)piperidin-1- yl)ethyl) acrylamid mit ccr-3-rezeptor antagonistischer wirkung zur verwendung bei der behandlung von entzündungen und allergischen leiden
UA27738C2 (uk) 2,3,4,5,6,7-гексагідро-1-[4-[1-[4-(2метоксифеніл)піперазиніл]]-2-фенілбутирил]-1н-азепін або його фармацевтично прийнятна кислотно-адитивна сіль, що мають властивість пов'язувати рецептор 5нт1а, спосіб (варіанти) їх одержання, фармацевтична композиція

Legal Events

Date Code Title Description
MK1K Patent expired